tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SXTP Stock Latest News

60 Degrees expands tafenoquine clinical trial to Brigham and Women’s Hospital
The Fly60 Degrees expands tafenoquine clinical trial to Brigham and Women’s Hospital
11d ago
SXTP
60 Degrees Pharmaceuticals launches Arakoda promotional pilot
PremiumThe Fly
60 Degrees Pharmaceuticals launches Arakoda promotional pilot
3M ago
SXTP
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
PremiumThe Fly
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
4M ago
SXTP
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
PremiumThe Fly
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
4M ago
SXTP
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
PremiumThe Fly
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
4M ago
SXTP
60 Degrees Pharmaceuticals Inc trading halted, news pending
PremiumThe Fly60 Degrees Pharmaceuticals Inc trading halted, news pending
4M ago
SXTP
60 Degrees Pharmaceuticals announces 1-for-12 reverse stock split
Premium
The Fly
60 Degrees Pharmaceuticals announces 1-for-12 reverse stock split
5M ago
SXTP
60 Degrees Pharmaceuticals awarded contract with U.S. Army for ARAKODA
Premium
The Fly
60 Degrees Pharmaceuticals awarded contract with U.S. Army for ARAKODA
5M ago
SXTP
60 Degrees signs trial agreements with planned sites for Tafenoquine
PremiumThe Fly
60 Degrees signs trial agreements with planned sites for Tafenoquine
5M ago
SXTP
60 Degrees Pharmaceuticals files $15M mixed securities shelf
PremiumThe Fly
60 Degrees Pharmaceuticals files $15M mixed securities shelf
5M ago
SXTP
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
PremiumThe Fly
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
6M ago
SXTP
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
PremiumThe Fly
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
6M ago
SXTP
60 Degrees Pharmaceuticals receives FDA ODD for Tafenoquine
PremiumThe Fly60 Degrees Pharmaceuticals receives FDA ODD for Tafenoquine
6M ago
SXTP
60 Degrees Pharmaceuticals’ treatment of babesiosis gets FDA orphan designation
Premium
The Fly
60 Degrees Pharmaceuticals’ treatment of babesiosis gets FDA orphan designation
7M ago
SXTP
60 Degrees enters agreement with Tufts Medical Center for tafenoquine trial
Premium
The Fly
60 Degrees enters agreement with Tufts Medical Center for tafenoquine trial
7M ago
SXTP
60 Degrees Pharmaceuticals funds Babesia ssp testing
PremiumThe Fly
60 Degrees Pharmaceuticals funds Babesia ssp testing
7M ago
SXTP
60 Degrees Pharmaceuticals outlines upcoming trial of Tafenoquine
PremiumThe Fly
60 Degrees Pharmaceuticals outlines upcoming trial of Tafenoquine
8M ago
SXTP
60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
PremiumThe Fly
60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
8M ago
SXTP
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
PremiumThe Fly
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
9M ago
SXTP
60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine
PremiumThe Fly60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine
9M ago
SXTP
60 Degrees announces FDA communication on trial protocol submission
Premium
The Fly
60 Degrees announces FDA communication on trial protocol submission
9M ago
SXTP
60 Degrees Pharmaceuticals Embarks on Tafenoquine Research Partnership
Premium
Company Announcements
60 Degrees Pharmaceuticals Embarks on Tafenoquine Research Partnership
10M ago
8K
SXTP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >